The global varicose veins market is projected to grow at a CAGR of around 6% during the forecast period. Varicose veins are linked with heredity and are more common in women than in men. According to the National Institute of Health, pelvic vein reflux (PVR) trigger the development of varicose veins in women. According to the Chicago Vein Institute, the prevalence of the disease is more in women (55%) in comparison to men (45%). In the US over 40 million people suffer from varicose veins. Around 50% of the patients have a family history of varicose veins. Children have a 90% chance to develop varicose veins if both parents have varicose veins. The increasing prevalence of varicose veins is driving the growth of the market across the globe.

However, some factors are restraining the market growth such as the high cost of surgery and laser treatment and the risk associated with surgical treatment. Besides, medical tourism will further create growth opportunities for the varicose veins treatment market across the globe.

Segmental Outlook 

The global varicose veins treatment market is segmented on the basis of medical procedures into endovenous ablation, sclerotherapy, and stripping. Sclerotherapy, endovenous ablation, and stripping are the basic options available for the treatment of varicose veins. Among these, the sclerotherapy segment is estimated to contribute a prominent share in the varicose vein treatment market owing to the benefits offered by it. In addition, the increasing need for minimal incision during the treatment procedures further contributes to the segmental growth of the market.

Global Varicose Veins Treatment Market Share by Medical Procedure, 2020 (%)

Regional Outlooks

Geographically, the study of the global varicose veins treatment market covers the analysis of four major regions North America, Europe, Asia-Pacific, and the Rest of the World. North America is considered to be the dominating region in the global varicose veins treatment market. The increasing prevalence of varicose veins coupled with the rising obesity among the US population and increasing geriatric population is estimated to be the major factors contributing to the growth of the market. Moreover, the presence of well-established healthcare infrastructure in the region further gives a boost to the regional growth of the market.

Further, Asia-Pacific is estimated to exhibit considerable growth during the forecast period. China, India, and Japan are the major contributing economies driving the growth of the Asia-Pacific varicose veins treatment market. The improving healthcare infrastructure in the region drives the regional growth of the market.

Market Players Outlook

The study of the global varicose veins treatment market report also covers the analysis of various players operating in the market. Some of the key players covered in the report include Medtronic Plc, AngioDynamics, Inc., Biolitec AG, Lumenis Ltd., Quanta Systems S.p.A., Eufoton S.R.L, and others. In order to survive in the market, these players adopt different marketing strategies such as mergers and acquisitions, product launches, and geographical expansion. For instance, in October 2020, Theraclion obtained a CE mark for its second generation of Sonovein, its HIFU (High-intensity focused ultrasound) treatment solution for varicose veins. It has also signed a strategic supplier partnership with SuperSonic Imaging (part of Hologic Inc.).

The Report Covers

• Market value data analysis of 2020 and forecast to 2027.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global varicose veins treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.